Feed aggregator

Court to rule on whether gravely ill UK child can go to Vatican hospital

Health News-RSS Feeds - 1 hour 28 min ago
LIVERPOOL, England (Reuters) - A British court will hear an appeal on Wednesday in the case of a gravely ill, 23-month-old boy whose case has attracted international attention, including from Pope Francis.

Novartis' digital drive continues with eye-disease app

Health News-RSS Feeds - 7 hours 22 min ago
ZURICH (Reuters) - Novartis's foray into digital technology intensified on Wednesday as the Swiss drugmaker launched a mobile-phone based app to help collect data from people participating in eye disease studies.

Hearing loss tied to higher risk of accidental injuries

Health News-RSS Feeds - 15 hours 50 min ago
(Reuters Health) - People who have a lot of trouble hearing may be almost twice as likely to experience an accidental injury as individuals with excellent or good hearing, a U.S. study suggests.

Caffeine in pregnancy tied to childhood weight gain

Health News-RSS Feeds - 18 hours 1 min ago
(Reuters Health) - Pregnant women who drink lots of coffee and other caffeinated beverages may be more likely to have kids who are overweight than mothers who limit caffeine during pregnancy, a Norwegian study suggests.

For elderly, opioids tied to higher risk of fall-related injuries and deaths

Health News-RSS Feeds - 18 hours 21 min ago
(Reuters Health) - Elderly people who are prescribed opioids may be at higher risk for injuries from falls, some of which may be fatal, a Canadian analysis of trauma cases suggests.

Express Scripts targets Amgen, Lilly migraine drugs in pricing shift

Health News-RSS Feeds - 19 hours 23 min ago
LOS ANGELES (Reuters) - The largest U.S. manager of prescription benefits is telling drugmakers that the current pricing model is broken, and taking aim at Amgen Inc, Eli Lilly and Co and other makers of new migraine medicines to try and fix it.

FDA cracks down on sales of Juul tobacco products to minors

Health News-RSS Feeds - April 24, 2018 - 9:47pm
(Reuters) - The U.S. Food and Drug Administration on Tuesday said it launched a crackdown to curb the sale to minors of e-cigarettes and other tobacco products developed by Juul Labs Inc.

FDA reveals 40 warning letters to e-cigarette retailers for sales to youth

Health News-RSS Feeds - April 24, 2018 - 8:56pm
(Reuters) - The U.S. Food and Drug Administration on Tuesday said it had issued 40 warning letters to retailers as part of its crackdown on illegal sales of Juul and other e-cigarettes to youth.

Malaria on rise in crisis-hit Venezuela, WHO says

Health News-RSS Feeds - April 24, 2018 - 6:46pm
GENEVA (Reuters) - Malaria is spreading rapidly in crisis-hit Venezuela, with more than an estimated 406,000 cases in 2017, up roughly 69 percent from a year before, the largest increase worldwide, the World Health Organization (WHO) said on Tuesday.

Ireland wins EU OK to tax sugary drinks on health grounds

Health News-RSS Feeds - April 24, 2018 - 4:43pm
BRUSSELS (Reuters) - Ireland gained EU approval on Tuesday for a tax on sugary drinks after regulators said the levy would help the country tackle health and obesity issues.

AstraZeneca flop a fresh blow to cancer immunotherapy combination

Health News-RSS Feeds - April 24, 2018 - 2:36pm
LONDON (Reuters) - The concept of combining two immunotherapy drugs to fight lung cancer - not so long ago one of the hottest ideas in cancer research - has suffered a fresh blow from the failure of an AstraZeneca clinical study.

UK bans Sanofi epilepsy drug without pregnancy prevention plan

Health News-RSS Feeds - April 24, 2018 - 2:02pm
LONDON (Reuters) - A Sanofi drug for epilepsy and bipolar disorder linked to thousands of birth defects has been banned in Britain for use in women or girls of child-bearing age, unless they are on a special pregnancy prevention program.

Ex-Roche scientist Reed to head Sanofi R&D as Zerhouni retires

Health News-RSS Feeds - April 24, 2018 - 12:59pm
(Reuters) - Sanofi said on Tuesday it had hired former Roche top scientist John Reed to head its research operations from July 1, when Elias Zerhouni retires from the French drugmaker.

AstraZeneca third-line lung cancer combination study fails

Health News-RSS Feeds - April 24, 2018 - 12:06pm
LONDON (Reuters) - A combination of AstraZeneca immunotherapy drugs in lung cancer patients who have already received at least two previous treatments has failed to show a benefit in slowing disease progression or helping patients live longer.

Express Scripts targets new migraine drugs to change U.S. pricing dynamic

Health News-RSS Feeds - April 24, 2018 - 10:40am
LOS ANGELES (Reuters) - The largest U.S. manager of prescription benefits is telling drugmakers that the current pricing model is broken, and taking aim at Amgen Inc and other makers of new migraine medicines to try and fix it.

Heavy drinking linked to worse PMS

Health News-RSS Feeds - April 24, 2018 - 4:19am
(Reuters Health) - Women who are heavy drinkers are at increased risk of pre-menstrual syndrome (PMS), new research shows.

FDA panel against higher dose of Lilly-Incyte arthritis drug

Health News-RSS Feeds - April 24, 2018 - 4:15am
(Reuters) - An arthritis drug developed by Eli Lilly & Co and Incyte Corp should not be approved at a 4-milligram dose, advisers to the U.S. FDA voted on Monday, in a setback to the drugmakers that were counting on the treatment as a future blockbuster.

Magnetic fields in electric cars don't seem to cause pacemaker problems

Health News-RSS Feeds - April 24, 2018 - 3:32am
(Reuters Health) - Electromagnetic fields produced by motors in electric cars don’t appear strong enough to interfere with implanted heart devices like pacemakers and defibrillators, a small German study suggests.

FDA panel backs lower dose of Lilly-Incyte arthritis drug over higher

Health News-RSS Feeds - April 24, 2018 - 2:56am
(Reuters) - A rheumatoid arthritis drug developed by Eli Lilly and Incyte Corp should not be approved at a higher dose, a U.S. Food and Drug Administration advisory committee voted on Monday, while backing the approval of a lower dose.

FDA panel votes against approving higher dose of Lilly-Incyte arthritis drug

Health News-RSS Feeds - April 24, 2018 - 2:35am
(Reuters) - A U.S. FDA advisory committee voted 10-to-5 on Monday against approving a higher dose of a rheumatoid arthritis drug developed by Eli Lilly & Co and Incyte Corp, but recommended that it be approved in a lower dose.